{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T05:00:50Z","timestamp":1666328450203},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T00:00:00Z","timestamp":1658275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00292-022-01095-z","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T10:02:41Z","timestamp":1658311361000},"page":"449-453","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Seltene Differenzialdiagnose bei bilateraler Gonalgie"],"prefix":"10.1007","volume":"43","author":[{"given":"Michael","family":"Mayr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Zojer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siroos","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Chott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,20]]},"reference":[{"key":"1095_CR1","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF01942684","volume":"279","author":"W Chester","year":"1930","unstructured":"Chester\u00a0W (1930) \u00dcber Lipoidgranulomatose. Virchows Arch path Anat 279:561\u2013602","journal-title":"Virchows Arch path Anat"},{"key":"1095_CR2","volume-title":"WHO classification of tumours of Haematopoietic and lymphoid tissues","author":"E Campo","year":"2017","unstructured":"Campo\u00a0E, Harris\u00a0NL, Pileri\u00a0SA, Jaffe\u00a0ES, Stein\u00a0H, Thiele\u00a0J (2017) WHO classification of tumours of Haematopoietic and lymphoid tissues, 4.\u00a0Aufl. IARC","edition":"4"},{"issue":"10","key":"1095_CR3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/annrheumdis-2012-202542","volume":"72","author":"G Cavalli","year":"2013","unstructured":"Cavalli\u00a0G, Guglielmi\u00a0B, Berti\u00a0A, Campochiaro\u00a0C, Sabbadini\u00a0MG, Dagna\u00a0L (2013) The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: comprehensive review of the literature and of 10 new cases. Ann Rheum Dis 72(10):1691\u20131695","journal-title":"Ann Rheum Dis"},{"issue":"22","key":"1095_CR4","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1182\/blood.2019003507","volume":"135","author":"G Goyal","year":"2020","unstructured":"Goyal\u00a0G, Heaney\u00a0ML, Collin\u00a0M, Cohen-Aubart\u00a0F, Vaglio\u00a0A, Durham\u00a0BH, Hershkovitz-Rokah\u00a0O, Girschikofsky\u00a0M, Jacobsen\u00a0ED, Toyama\u00a0K, Goodman\u00a0AM, Hendrie\u00a0P, Cao\u00a0XX, Estrada-Veras\u00a0JI, Shpilberg\u00a0O, Abdo\u00a0A, Kurokawa\u00a0M, Dagna\u00a0L, McClain\u00a0KL, Mazor\u00a0RD, Picarsic\u00a0J, Janku\u00a0F, Go\u00a0RS, Haroche\u00a0J, Diamond\u00a0EL (2020) Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 135(22):1929\u20131945","journal-title":"Blood"},{"issue":"12","key":"1095_CR5","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1634\/theoncologist.2018-0295","volume":"23","author":"PA Oneal","year":"2018","unstructured":"Oneal\u00a0PA, Kwitkowski\u00a0V, Luo\u00a0L, Shen\u00a0YL, Subramaniam\u00a0S, Shord\u00a0S, Goldberg\u00a0KB, McKee\u00a0AE, Kaminskas\u00a0E, Farrell\u00a0A, Pazdur\u00a0R (2018) FDA approval summary: vemurafenib for the treatment of patients with Erdheim-Chester disease with the BRAFV600 mutation. The Oncol 23(12):1520\u20131524","journal-title":"The Oncol"},{"issue":"1","key":"1095_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","volume":"95","author":"M Cives","year":"2015","unstructured":"Cives\u00a0M, Simone\u00a0V, Rizzo\u00a0FM, Dicuonzo\u00a0F, Cristallo Lacalamita\u00a0M, Ingravallo\u00a0G, Silvestris\u00a0F, Dammacco\u00a0F (2015) Erdheim-Chester disease: a\u00a0systematic review. Crit Rev Oncol Hematol 95(1):1\u201311","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"1095_CR7","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.3324\/haematol.2018.201194","volume":"104","author":"S Melloul","year":"2019","unstructured":"Melloul\u00a0S, H\u00e9lias-Rodzewicz\u00a0Z, Cohen-Aubart\u00a0F, Charlotte\u00a0F, Fraitag\u00a0S, Terrones\u00a0N, Riller\u00a0Q, Chazal\u00a0T, H\u00e9ritier\u00a0S, Moreau\u00a0A, Kambouchner\u00a0M, Copin\u00a0MC, Donadieu\u00a0J, Taly\u00a0V, Amoura\u00a0Z, Haroche\u00a0J, Emile\u00a0JF (2019) Highly sensitive methods are required to detect mutations in histiocytoses. Haematologica 104(3):e97\u2013e99","journal-title":"Haematologica"},{"key":"1095_CR8","unstructured":"(2022) Submissions for variant NM_001123385.2(BCOR) :c.3487C\u3009T (p.Arg1163Ter) (rs1935081157). Clin Var Miner. https:\/\/clinvarminer.genetics.utah.edu\/submissions-by-variant\/NM_001123385.2%28BCOR%29%3Ac.3487C%3ET%20%28p.Arg1163Ter%29 (Erstellt: 1. Juli 2022). Zugegriffen: 28.06.2022"},{"key":"1095_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.exphem.2021.07.005","volume":"101\u2013102","author":"A Honda","year":"2021","unstructured":"Honda\u00a0A, Koya\u00a0J, Yoshimi\u00a0A, Miyauchi\u00a0M, Taoka\u00a0K, Kataoka\u00a0K, Arai\u00a0S, Kurokawa\u00a0M (2021) Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia. Exp Hematol 101\u2013102:42\u201348.e11","journal-title":"Exp Hematol"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-022-01095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-022-01095-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-022-01095-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T12:05:09Z","timestamp":1666267509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-022-01095-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,20]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1007\/s00292-022-01095-z","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,20]]},"assertion":[{"value":"5 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Mayr, N.\u00a0Zojer, S.\u00a0Mirzaei und A.\u00a0Chott geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}